News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
736,587 Results
Type
Article (43204)
Company Profile (274)
Press Release (693097)
Multimedia
Podcasts (87)
Webinars (19)
Section
Business (208979)
Career Advice (2119)
Deals (36020)
Drug Delivery (116)
Drug Development (82517)
Employer Resources (177)
FDA (16602)
Job Trends (15173)
News (352825)
Policy (33317)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2657)
Accelerated approval (32)
Adcomms (30)
Allergies (142)
Alliances (50540)
ALS (170)
Alzheimer's disease (1688)
Antibody-drug conjugate (ADC) (317)
Approvals (16870)
Artificial intelligence (521)
Autoimmune disease (154)
Automation (39)
Bankruptcy (364)
Best Places to Work (11778)
BIOSECURE Act (20)
Biosimilars (192)
Biotechnology (175)
Bladder cancer (157)
Brain cancer (57)
Breast cancer (647)
Cancer (4848)
Cardiovascular disease (401)
Career advice (1793)
Career pathing (38)
CAR-T (286)
CDC (45)
Celiac Disease (2)
Cell therapy (757)
Cervical cancer (36)
Clinical research (70421)
Collaboration (1728)
Company closure (4)
Compensation (1157)
Complete response letters (54)
COVID-19 (2744)
CRISPR (90)
C-suite (859)
Cystic fibrosis (143)
Data (6261)
Decentralized trials (2)
Denatured (29)
Depression (132)
Diabetes (508)
Diagnostics (6821)
Digital health (50)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (258)
Drug pricing (190)
Drug shortages (28)
Duchenne muscular dystrophy (232)
Earnings (91999)
Editorial (58)
Employer branding (21)
Employer resources (155)
Events (120002)
Executive appointments (986)
FDA (19734)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1485)
Gene editing (196)
Generative AI (44)
Gene therapy (607)
GLP-1 (983)
Government (4758)
Grass and pollen (6)
Guidances (384)
Healthcare (19185)
HIV (60)
Huntington's disease (44)
IgA nephropathy (83)
Immunology and inflammation (250)
Immuno-oncology (58)
Indications (110)
Infectious disease (3017)
Inflammatory bowel disease (191)
Inflation Reduction Act (14)
Influenza (117)
Intellectual property (250)
Interviews (328)
IPO (16841)
IRA (50)
Job creations (3734)
Job search strategy (1504)
JPM (57)
Kidney cancer (16)
Labor market (86)
Layoffs (556)
Leadership (34)
Legal (8083)
Liver cancer (92)
Longevity (14)
Lung cancer (656)
Lymphoma (376)
Machine learning (42)
Management (61)
Manufacturing (803)
MASH (164)
Medical device (14016)
Medtech (14071)
Mergers & acquisitions (20257)
Metabolic disorders (1286)
Multiple sclerosis (161)
NASH (16)
Neurodegenerative disease (322)
Neuropsychiatric disorders (88)
Neuroscience (2927)
Neurotech (1)
NextGen: Class of 2026 (6629)
Non-profit (4623)
Now hiring (67)
Obesity (607)
Opinion (267)
Ovarian cancer (166)
Pain (199)
Pancreatic cancer (230)
Parkinson's disease (286)
Partnered (34)
Patents (498)
Patient recruitment (492)
Peanut (56)
People (60185)
Pharmaceutical (66)
Pharmacy benefit managers (29)
Phase 1 (21939)
Phase 2 (30970)
Phase 3 (23081)
Pipeline (5295)
Policy (284)
Postmarket research (2651)
Preclinical (9363)
Press Release (64)
Prostate cancer (241)
Psychedelics (50)
Radiopharmaceuticals (280)
Rare diseases (842)
Real estate (6103)
Recruiting (71)
Regulatory (24904)
Reports (52)
Research institute (2455)
Resumes & cover letters (361)
Rett syndrome (27)
RNA editing (16)
RSV (77)
Schizophrenia (150)
Series A (240)
Series B (190)
Service/supplier (11)
Sickle cell disease (97)
Special edition (21)
Spinal muscular atrophy (158)
Sponsored (42)
Startups (3671)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (86)
The Weekly (56)
Vaccines (1020)
Venture capital (90)
Weight loss (391)
Women's health (93)
Worklife (19)
Date
Today (104)
Last 7 days (616)
Last 30 days (2135)
Last 365 days (30196)
2026 (3457)
2025 (30477)
2024 (35530)
2023 (40492)
2022 (51677)
2021 (56302)
2020 (54766)
2019 (47457)
2018 (35740)
2017 (32832)
2016 (32300)
2015 (38442)
2014 (32127)
2013 (27105)
2012 (29398)
2011 (30031)
2010 (28126)
Location
Africa (782)
Alabama (83)
Alaska (7)
Arizona (313)
Arkansas (13)
Asia (40773)
Australia (6717)
California (11338)
Canada (3293)
China (1121)
Colorado (479)
Connecticut (479)
Delaware (337)
Europe (89065)
Florida (1691)
Georgia (356)
Hawaii (3)
Idaho (61)
Illinois (866)
India (67)
Indiana (522)
Iowa (22)
Japan (436)
Kansas (127)
Kentucky (38)
Louisiana (26)
Maine (83)
Maryland (1393)
Massachusetts (8137)
Michigan (331)
Minnesota (634)
Mississippi (5)
Missouri (137)
Montana (32)
Nebraska (28)
Nevada (122)
New Hampshire (79)
New Jersey (3010)
New Mexico (28)
New York (2988)
North Carolina (1489)
North Dakota (8)
Northern California (5526)
Ohio (344)
Oklahoma (22)
Oregon (41)
Pennsylvania (2280)
Puerto Rico (24)
Rhode Island (48)
South America (1156)
South Carolina (66)
South Dakota (1)
Southern California (4421)
Tennessee (174)
Texas (1758)
United States (40272)
Utah (337)
Vermont (1)
Virginia (261)
Washington D.C. (83)
Washington State (921)
West Virginia (4)
Wisconsin (114)
Wyoming (2)
736,587 Results for "sterigenics international inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Clordisys Strengthens Leadership Team with Addition of Former Sterigenics Leaders to Support Growth and Continued Scaling of Contract Sterilization Operations
February 11, 2026
·
3 min read
Press Releases
Oncotelic Therapeutics, Inc. and Sapu Bioscience Expand International IP Coverage for OT-101, Strengthening CNS and Neurology Commercialization Pathway
February 12, 2026
·
6 min read
Press Releases
Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026)
January 15, 2026
·
6 min read
Job Trends
Talent Acquisition Leaders Reframe Recruiting, Focus On Internal Mobility
Talent acquisition leaders at leading pharma and biotech organizations are leveraging technologies
,
including automation
,
to develop internal talent marketplaces and systems that support upskilling and reskilling their workforce.
BioSpace
spoke to leaders at Pfizer and Bayer about their evolving approach to resourcing.
September 24, 2025
·
3 min read
·
Chantal Dresner
Press Releases
BioSyent to Acquire Oral Science Inc.
February 9, 2026
·
10 min read
Press Releases
Dyadic International, Inc. Announces Strategic Rebrand to Dyadic Applied BioSolutions
July 3, 2025
·
5 min read
Press Releases
TLX250-CDx (Zircaix) Included in Leading International Guidelines for Renal Imaging
October 23, 2025
·
9 min read
Press Releases
Citius Oncology Expands International Distribution of LYMPHIR™ to European Union Through Exclusive Agreement with Uniphar
February 11, 2026
·
10 min read
Business
Basel Life Sciences Scene Embraces International Companies, Startups
The Basel area is home to over 800 life sciences companies, including Novartis and Roche, according to nonprofit Basel Area Business & Innovation. The nonprofit’s CEO and a BeOne Medicines executive discuss the location’s evolution, advantages and future.
November 6, 2025
·
6 min read
·
Angela Gabriel
FDA
FDA’s Prasad Weathers Personal Controversy, Internal Strife Amid Moderna Imbroglio
Vinay Prasad, the FDA’s Center for Biologics Evaluation and Research head, is accused of interpersonal impropriety as pushback builds against his decision to reject Moderna’s influenza vaccine candidate.
February 12, 2026
·
2 min read
·
Dan Samorodnitsky
1 of 73,659
Next
